Literature DB >> 1697563

Cell populations in the human early pregnancy decidua: natural killer activity and response to interleukin-2 of CD56-positive large granular lymphocytes.

B L Ferry1, P M Starkey, I L Sargent, G M Watt, M Jackson, C W Redman.   

Abstract

Large granular lymphocytes (LGL) have been shown previously to be the most abundant cell type in the first trimester human decidua. Purified populations of decidual LGL were prepared by flow cytometry of cell dispersions labelled with NKH1 (CD56), an antibody specific for peripheral blood LGL, and the functional properties of CD56-positive cells, CD56-negative and unsorted decidual cells compared. Both CD56-positive cells and unsorted decidual cells have cytotoxic activity against the natural killer (NK) cell target K562 which was weak compared with that of peripheral blood mononuclear cells (PBMC). The CD56-negative cells had no cytotoxic activity against K562. All three decidual cell populations proliferated in response to recombinant human interleukin-2 (rIL-2), but none produced detectable levels of IL-2 in culture. When unsorted decidual cells were cultured for 7 days in rIL-2 the proportion of CD56-positive cells increased and NK activity against K562 was augmented. The NK activity of purified CD56-positive decidual cells was also augmented by culturing in rIL-2. The potential role of decidual LGL in regulating the development of the semi-allogeneic placenta is discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1697563      PMCID: PMC1384247     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  33 in total

1.  Natural killer (NK) cell activity of first trimester human decidua.

Authors:  S Manaseki; R F Searle
Journal:  Cell Immunol       Date:  1989-06       Impact factor: 4.868

2.  Isolation and functional studies of granulated lymphocytes in first trimester human decidua.

Authors:  A Ritson; J N Bulmer
Journal:  Clin Exp Immunol       Date:  1989-08       Impact factor: 4.330

3.  Cell populations in human early pregnancy decidua: characterization and isolation of large granular lymphocytes by flow cytometry.

Authors:  P M Starkey; I L Sargent; C W Redman
Journal:  Immunology       Date:  1988-09       Impact factor: 7.397

4.  The effects of IL-4 on human natural killer cells. A potent regulator of IL-2 activation and proliferation.

Authors:  A Nagler; L L Lanier; J H Phillips
Journal:  J Immunol       Date:  1988-10-01       Impact factor: 5.422

5.  Characterization of hematogenous cellular constituents of the murine decidua: a surface marker study.

Authors:  M Kearns; P K Lala
Journal:  J Reprod Immunol       Date:  1985-11       Impact factor: 4.054

6.  Early human decidual cells exhibit NK activity against the K562 cell line but not against first trimester trophoblast.

Authors:  A King; C Birkby; Y W Loke
Journal:  Cell Immunol       Date:  1989-02       Impact factor: 4.868

7.  Characterization of murine decidual natural killer (NK) cells and their relevance to the success of pregnancy.

Authors:  B A Croy; P Gambel; J Rossant; T G Wegmann
Journal:  Cell Immunol       Date:  1985-07       Impact factor: 4.868

8.  Proliferative activity in endometrial stromal granulocytes throughout menstrual cycle and early pregnancy.

Authors:  D Pace; L Morrison; J N Bulmer
Journal:  J Clin Pathol       Date:  1989-01       Impact factor: 3.411

9.  Characteristics of human large granular lymphocytes and relationship to natural killer and K cells.

Authors:  T Timonen; J R Ortaldo; R B Herberman
Journal:  J Exp Med       Date:  1981-03-01       Impact factor: 14.307

10.  Positive self regulation of cytotoxicity in human natural killer cells by production of interferon upon exposure to influenza and herpes viruses.

Authors:  J Y Djeu; N Stocks; K Zoon; G J Stanton; T Timonen; R B Herberman
Journal:  J Exp Med       Date:  1982-10-01       Impact factor: 14.307

View more
  17 in total

1.  Decidual T lymphocyte activation in hydatidiform mole.

Authors:  S Wongweragiat; R F Searle; J N Bulmer
Journal:  J Clin Pathol       Date:  1999-12       Impact factor: 3.411

2.  Chemokine ligand and receptor expression in the pregnant uterus: reciprocal patterns in complementary cell subsets suggest functional roles.

Authors:  K Red-Horse; P M Drake; M D Gunn; S J Fisher
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

Review 3.  Chemokine expression and function at the human maternal-fetal interface.

Authors:  Penelope M Drake; Kristy Red-Horse; Susan J Fisher
Journal:  Rev Endocr Metab Disord       Date:  2002-05       Impact factor: 6.514

Review 4.  The placenta revealed.

Authors:  H J Kliman
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

5.  Expression on cells of early human pregnancy decidua, of the p75, IL-2 and p145, IL-4 receptor proteins.

Authors:  P M Starkey
Journal:  Immunology       Date:  1991-05       Impact factor: 7.397

6.  Natural killer-cell deficiency alters placental development in rats.

Authors:  Stephen J Renaud; Regan L Scott; Damayanti Chakraborty; Mohammad A K Rumi; Michael J Soares
Journal:  Biol Reprod       Date:  2017-01-01       Impact factor: 4.285

7.  Morphological, phenotypic and functional characteristics of a pure population of CD56+ CD16- CD3- large granular lymphocytes generated from human duodenal mucosa.

Authors:  G Pang; A Buret; R T Batey; Q Y Chen; L Couch; A Cripps; R Clancy
Journal:  Immunology       Date:  1993-07       Impact factor: 7.397

Review 8.  Innate immunity, coagulation and placenta-related adverse pregnancy outcomes.

Authors:  Min Li; S Joseph Huang
Journal:  Thromb Res       Date:  2009-08-14       Impact factor: 3.944

Review 9.  Uterine NK cells: active regulators at the maternal-fetal interface.

Authors:  Ashley Moffett; Francesco Colucci
Journal:  J Clin Invest       Date:  2014-05-01       Impact factor: 14.808

Review 10.  Chronic Inflammatory Placental Disorders Associated With Recurrent Adverse Pregnancy Outcome.

Authors:  Emily F Cornish; Thomas McDonnell; David J Williams
Journal:  Front Immunol       Date:  2022-04-22       Impact factor: 8.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.